药品专利保护惩罚性赔偿的必要性探讨  

Necessity of Punitive Damages for Pharmaceutical Patent Protection

作　　者：邵辰杰[1] 田侃[1] 喻小勇[1] 

机构地区：[1]南京中医药大学经贸管理学院,南京210023

出　　处：《中国药房》2014年第33期3073-3076,共4页China Pharmacy

基　　金：国家中医药管理局中医药法制体系建设项目(No.ZYYP-2012〔01〕)

摘　　要：目的:为加强我国药品专利保护提出立法建议。方法:通过对我国药品专利保护立法状况的梳理,分析我国药品专利保护的现状;通过惩罚性赔偿的法理学以及建立博弈支付矩阵,探求惩罚性赔偿适用的合理性及经济性。结果:我国已形成以知识产权法为主、多层级法律规范为辅的药品专利保护制度,惩罚性赔偿的适用具备法理学基础,博弈模型结果表明高额赔偿金对药品专利具有双重保护作用。结论:我国有必要在现阶段的药品专利保护中引入惩罚性赔偿制度,以提高药品专利侵权人的侵权成本,激发专利权人维权的积极性。OBJECTIVE： To provide legislative suggestions to strengthen pharmaceutical patent protection in China. METH- ODS： By hackling the status quo of pharmaceutical patent protection legislation in China, the situation of pharmaceutical patent protection was analyzed. The economy and rationality of punitive damages were explored through jurisprudence analysis and establishing game payoff matrix. RESULTS： The intellectual property law-based, multi-level legal norms supplemented pharmaceutical patent protection system had been formed in China. Punitive damages has jurisprudence application basis, and game theory model showed that the double protection effect of high compensation on drug damages for pharmaceutical patent protection at this time, so as to raise patent. CONCLUSIONS： It is necessary to apply punitive the drug patent infringement costs and to stimulate the enthusiasm of the patentee to fight for their rights.

关 键 词：药品专利 惩罚性赔偿 博弈分析 

分 类 号：R95[医药卫生—药学]